ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Journal of Environmental Pathology, Toxicology and Oncology
インパクトファクター: 1.625 5年インパクトファクター: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN 印刷: 0731-8898
ISSN オンライン: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.2016015463
pages 91-98

Comparing the Effects of Light- or Sonic-Activated Drug Delivery: Photochemical/Sonochemical Internalization

Steen J. Madsen
Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Pkwy., Box 453037, Las Vegas, NV 89154
Jonathan Gonzales
Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA 92612
Genesis Zamora
Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA 92612
Kristian Berg
Oslo University Hospital, The Norwegian Radium Hospital, Dept. of Radiation Biology, Oslo, 0379, Norway
Rohit Kumar Nair
Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA 92612
Henry Hirschberg
Beckman Laser Institute, University of California, Irvine, 1002 Health Sciences Rd. E, Irvine, CA 92612

要約

Photochemical internalization (PCI) is a technique that uses the photochemical properties of photodynamic therapy (PDT) for the enhanced delivery of endolysosomal-trapped macromolecules into the cell cytoplasm. The released agent can therefore exert its full biological activity, in contrast to being degraded by lysosomal hydrolases. Activation of photosensitizers via ultrasound (US), called sonodynamic therapy (SDT), has been proposed as an alternative to light-activated PDT for the treatment of cancerous tumors. The use of focused US (FUS) to activate photosensitizers allows treatment at tumor sites buried deep within tissues, overcoming one of the main limitations of PDT/PCI. We have examined ultrasonic activation of photosensitizers together with the anticancer agent bleomycin (BLM) using sonochemical internalization (SCI), as an alternative to light-activated PCI. Our results indicate that, compared to drug or US treatment alone, US activation of the photosensitizer AlPcS2a together with BLM significantly inhibits the ability of treated glioma cells to form clonogenic colonies.


Articles with similar content:

Activating Photodynamic Therapy in vitro with Cerenkov Radiation Generated from Yttrium-90
Journal of Environmental Pathology, Toxicology and Oncology, Vol.35, 2016, issue 2
Brad A. Hartl, Henry Hirschberg, Laura Marcu, Simon R. Cherry
Preface: Special Issue of Photodynamic Therapy and Photodetection with Porphyrin Precursors for the Journal of Environmental Pathology, Toxicology, and Oncology
Journal of Environmental Pathology, Toxicology and Oncology, Vol.26, 2007, issue 2
Alcira Batlle, Qian Peng
Induction of Apoptosis by Hexaminolevulinate-Mediated Photodynamic Therapy in Human Colon Carcinoma Cell Line 320DM
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Hela Soltani, Jahn M. Nesland, Trond Stokke, Susan Shahzidi, Qian Peng
Viability of Human Blood Leukocytes Compared with Their Respective Cell Lines after Plasma Treatment
Plasma Medicine, Vol.3, 2013, issue 1-2
Helena Tresp, Sander Bekeschus, Ulrike Lindequist, Stephan Reuter, Sybille Hasse, Lena Bundscherer, Kai Masur, Klaus-Dieter Weltmann
Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Carlos L. Arteaga, Brent N. Rexer